Nanoparticle Delivery

Nanoparticles enable the delivery of substances, including nucleic acids and chemotherapeutic drugs, to a targeted region while sparing healthy tissues, thus overcoming adverse systemic effects of gene therapy or drug delivery. Here is the latest research on nanoparticle delivery.

February 26, 2021
Open Access

In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery.

International Journal of Nanomedicine
Hongfei XuJingling Tang
February 26, 2021

Supramolecular metal-based nanoparticles for drug delivery and cancer therapy.

Current Opinion in Chemical Biology
Xiaomin JiangWenbin Lin
February 25, 2021
Open Access

Self-Navigated 3D Acoustic Tweezers in Complex Media Based on Time Reversal.

Research : a Science Partner Journal
Ye YangHairong Zheng
February 25, 2021

Stimuli-responsive metal-organic framework nanoparticles for controlled drug delivery and medical applications.

Chemical Society Reviews
Zhixin ZhouItamar Willner
February 25, 2021

Development and evaluation of proniosomes to enhance the transdermal delivery of cilostazole and to ensure the safety of its application.

Drug Development and Industrial Pharmacy
Asmaa Ashraf NemrHany Abdo Badie
February 24, 2021
Open Access

Nanophyto-gel against multi-drug resistant Pseudomonas aeruginosa burn wound infection.

Drug Delivery
Ming Ming WenSally A El-Zahaby
February 24, 2021
Open Access

CD44-targeted pH-responsive micelles for enhanced cellular internalization and intracellular on-demand release of doxorubicin.

Artificial Cells, Nanomedicine, and Biotechnology
Shudi YangTongtong Yu
February 23, 2021
Open Access

Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19.

Emergent Materials
Farzan Vahedifard, Krishnan Chakravarthy
February 23, 2021

Dual-Targeting Glycol Chitosan/Heparin-Decorated Polypyrrole Nanoparticle for Augmented Photothermal Thrombolytic Therapy.

ACS Applied Materials & Interfaces
Ting-Yu LuEr-Yuan Chuang
February 23, 2021

Nanomedicines in the treatment of colon cancer: a focus on metallodrugs.

Drug Delivery and Translational Research
Pedro FarinhaM Manuela Gaspar
February 20, 2021

Breath-Synchronized Nebulized Surfactant in a Porcine Model of Acute Respiratory Distress Syndrome.

Critical Care Explorations
Robert M DiBlasiMichael A Portman
February 19, 2021

Anti-Tumor Efficacy of Pyrvinium Pamoate Nanoliposomes in an Experimental Model of Melanoma.

Anti-cancer Agents in Medicinal Chemistry
Mahdi HatamipourAmirhossein Sahebkar

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved